Reducing Acute Filariasis Morbidity in Papua New Guinea
Author Information
Author(s): Daniel J. Tisch, Neal D. E. Alexander, Benson Kiniboro, Henry Dagoro, Peter M. Siba, Moses J. Bockarie, Michael P. Alpers, James W. Kazura
Primary Institution: Case Western Reserve University
Hypothesis
Does mass drug administration reduce acute filariasis morbidity by decreasing exposure to infective larvae?
Conclusion
Mass administration of anti-filarial drugs leads to a significant decrease in acute filariasis morbidity.
Supporting Evidence
- The incidence of acute filariasis morbidity decreased from 0.39 to 0.15 per person-year after two annual treatments.
- 92% of acute morbidity events lasted less than 3 weeks.
- Residents in high transmission areas experienced a greater reduction in morbidity compared to those in moderate transmission areas.
Takeaway
Giving medicine to people can help them feel better and stop their legs and arms from swelling up because of a worm infection.
Methodology
Weekly active surveillance for acute filariasis morbidity was conducted over 5 years, with data collected before and after 4 annual mass drug administrations.
Potential Biases
Self-reported data may introduce bias in the incidence of acute filariasis morbidity.
Limitations
The study relied on self-reported morbidity events and was conducted before current WHO recommendations for drug administration.
Participant Demographics
Participants were residents of Papua New Guinea, with varying levels of pre-treatment transmission intensity.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI = 1.14–1.61
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website